Anthony Walker, PhD, and Cort Hepler

Recent Posts

The realities of AI security in early-stage biotech

Contents What is at stake Where the data goes Reliability Shadow use and diligence A minimum viable policy Configuring what you own Culture and validation When you are asked A 90-day path FAQ...
Learn More

Pharma Due Diligence: Guilty Until Proven Innocent

Introduction Why the Burden Falls on You What DD Reveals Proving Innocence in Practice Navigating the Process When the Rule Breaks Down References Pharma Due Diligence: Guilty Until Proven Innocent...
Learn More

When Probability is Fiction: Risk vs. Uncertainty in Biotech Due Diligence

Introduction What is Risk? What is Uncertainty? Key Differences The Risk Matrix Fallacy Implications for Practice References Due Diligence Services Alacrita provides comprehensive due diligence...
Learn More

The Hidden Pitfalls of Unconscious Bias in Drug Development

Please be assured this is not a woke rant dealing with micro-aggressions or cultural stereotyping, but about something potentially much more impactful on drug development outcomes. It deals with the...
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

© 2009-25 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

Alacrita Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.